Related Experiment Videos
[Chlamydia pneumoniae: an cause of reactive arthritis?]
J Bernhard1, T Lehmann, P M Villiger
1Klinik für Rheumatologie und Klinische Immunologie/Allergologie, Inselspital Bern.
Abstract:
Chlamydia pneumoniae is a common cause of acute infections within the upper respiratory tract. It is less well known that chlamydia pneumoniae, just like chlamydia trachomatis, may also trigger reactive arthritis. We describe three patients with arthritis possibly triggered by chlamydia pneumoniae. The patients showed the typical symptoms of reactive arthritis like asymmetric oligo- or polyarthritis, dactylitis, enthesiopathies and tendovaginitis. The course of the disease was quite different. The first patient developed persistent polyarthritis which required longterm treatment with a rheumatic disease modifying drug; the second patient improved after several weeks and the third patient experienced a full remission within a few days.
Insights
Chlamydia pneumoniae can cause reactive arthritis, a condition typically linked to Chlamydia trachomatis. This study presents three cases of arthritis potentially triggered by Chlamydia pneumoniae infection.
Area of Science:
- Rheumatology
- Infectious Diseases
- Microbiology
Background:
- Chlamydia pneumoniae is a prevalent cause of upper respiratory tract infections.
- Reactive arthritis is commonly associated with Chlamydia trachomatis infections.
- The potential role of Chlamydia pneumoniae in triggering reactive arthritis is less understood.
Observation:
- Three patients presented with arthritis exhibiting symptoms consistent with reactive arthritis.
- Observed symptoms included asymmetric oligo- or polyarthritis, dactylitis, enthesiopathies, and tendovaginitis.
- Clinical presentations and disease progression varied significantly among the patients.
Findings:
- The study suggests Chlamydia pneumoniae as a potential trigger for reactive arthritis.
- Patient 1 developed persistent polyarthritis requiring long-term disease-modifying antirheumatic drug (DMARD) therapy.
- Patient 2 showed improvement within weeks, while Patient 3 experienced a rapid, full remission.
Implications:
- These findings expand the understanding of Chlamydia pneumoniae's pathogenic potential beyond respiratory infections.
- Highlights the need to consider Chlamydia pneumoniae in the differential diagnosis of reactive arthritis.
- Suggests diverse clinical trajectories for Chlamydia pneumoniae-induced reactive arthritis, impacting treatment strategies.